Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | The diagnostic work-up of CBCL

Jean-Philippe Merlio • 14 Oct 2021
EORTC CLTF 2021
B-Cell Lymphoma Cutaneous B-Cell Lymphoma Follicular Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases Antibodies Rituximab

Jean-Philippe Merlio, MD, PhD, Tumor Biology and Tumor Bank, CHU Bordeaux, Pessac, France, discusses the diagnosis of cutaneous B-cell lymphoma (CBCL), commenting on the particular significance of early diagnosis for large cell lymphomas. Prof. Merlio also talks on the importance of accurate diagnosis in the treatment of large B-cell lymphomas, highlighting the use of systemic therapy, rituximab and radiation therapy. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Jean-Philippe Merlio

1:05
Discrepancies in CBCL diagnosis
Jean-Philippe Merlio • 14 Oct 2021
1:19
Challenges in CBCL research
Jean-Philippe Merlio • 14 Oct 2021
0:48
Integrating data to improve CBCL diagnosis
Jean-Philippe Merlio • 14 Oct 2021

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals